X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

APTO

Closed

Aptose Biosciences Inc

2.03
+0.02 (+1.00%)
Last Update: 30 Apr 2025 16:30:00
Yesterday: 2.01
Day's Range: 2.03 - 2.06
Send
When Written:
 
0.64
Aptose Biosciences Inc. is a clinical-stage biotechnology company that focuses on the discovery, research, and development of targeted therapies to treat cancer and other life-threatening diseases. The company's lead product candidate, APTO-253, is a small molecule that inhibits the expression of the MYC oncogene, which is frequently overexpressed in many types of cancer. Aptose is also developing other small molecule inhibitors of cancer targets, including BCL-2 and FLT3, and has a pipeline of preclinical programs in various stages of development. The company is headquartered in San Diego, California, and has a research and development facility in Toronto, Canada. Aptose Biosciences was founded in 1986 and is publicly traded on the NASDAQ stock exchange under the ticker symbol APTO.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X